Centene Corporation announced that its senior management team will meet with investors on March 4, 2025, and reaffirm its 2025 full-year adjusted diluted earnings per share (EPS) guidance floor of greater than $7.25. This guidance was initially provided on February 4, 2025.

The company uses non-GAAP financial measures to help investors assess its core operations consistently across periods. These measures exclude amortization of acquired intangible assets, acquisition and divestiture-related expenses, and other items. Centene emphasizes that its non-GAAP financial measures may differ from those used by other companies and should not be viewed as a substitute for GAAP financial data.

The company also issued forward-looking statements regarding its financial and operational performance, regulatory changes, contract developments, and market conditions. These statements are subject to various risks, including competition, government reimbursement rates, changes in healthcare laws, cybersecurity threats, and economic factors.

Centene advises investors that its guidance remains effective only as of the date issued and will not be updated unless publicly reaffirmed.